Survodutide 10 mg
Dual GCGR/GLP-1R agonist with optimized receptor selectivity. ≥98% purity, 10 mg lyophilized. For laboratory research only.
🎟️ Available Coupons
AURA-BOGO 🛍️ Frequently Bought Together
- Dispatch within 24-48 Hours : Your product will be shipped quickly.
Description
Research Profile
Featuring optimized receptor selectivity ratios between GLP-1R and GCGR, Survodutide has been investigated in Phase II and III clinical trials for metabolic conditions. Its unique pharmacological profile enables researchers to study the synergistic effects of coordinated incretin and glucagon receptor engagement on energy expenditure and hepatic lipid metabolism.










Reviews
There are no reviews yet.